A phase 3 trial evaluating benralizumab for the treatment of COPD did not meet its primary endpoint, according to AstraZeneca.
Researchers found smoking marijuana was associated with significantly increased risk of asthma, including among people who have never used tobacco cigarettes, and may also be associated with chronic ...